Exploring Orthopedic Innovation Product Selection Conference | Multiple Domestic First-of-its-kind Innovations Gather in Wuxi
Susheng Biotech
Developer and Manufacturer of Sports Medicine Devices
Arthrone
Orthopedic Instrument R&D and Manufacturer
Susheng BiotechArthrone Co., Ltd.BORAYER [Polyester Collagen Bone Repair Material]
On February 10, 2025, Hainan Susheng Biotech Co., Ltd. ("Susheng Biotech") obtained the Class III medical device registration certificate issued by the National Medical Products Administration for the "Polyester Collagen Bone Repair Material" introduced from Switzerland. [Registration Certificate No.] GuoXieZhuJin 20253130077
This product is composed of bovine-derived cancellous bone (98.5±0.5%), poly-L-lactide-co-ε-caprolactone (1.0±0.2%), and gelatin (derived from porcine, 0.5±0.1%). The polymer of poly-L-lactide-co-ε-caprolactone contains 70% L-lactide and 30% ε-caprolactone. The product is available in block or granular form, sterilized with ethylene oxide, with a sterilization validity period of 4 years, for single use only.，Suitable for filling and repairing bone defects.
BORAYER | Absorbable Hemostatic Liquid GelatinFirst Chinese-Manufactured Registration Certificate
On September 7, 2023, Jiangxi Borayer Biotechnology Co., Ltd. ("BORAYER") independently developed and produced "Absorbable Hemostatic Liquid Gelatin" (trade name: Boray Flow).®) has passed the registration application of the National Medical Products Administration (NMPA) and has been approved for the Class III Medical Device Registration Certificate.This is also the first Chinese production registration certificate for "absorbable hemostatic liquid gelatin" products.(Registration Certificate No.:China Medical Device Registration Certificate 20233141303
It is reported that —— BORAYER's "Absorbable Hemostatic Flowable Gelatin" has the advantages of good fluidity, low swelling, efficient hemostasis, and absorbability, providing an excellent hemostatic solution for clinical use. It offers particularly prominent benefits in fields such as neurosurgery and spinal surgery.
Composition: This product consists of absorbable hemostatic gelatin powder encapsulated in a syringe, an empty syringe, a connector, a white injection catheter, a blue flexible injection catheter, and a pipette cup. The absorbable hemostatic gelatin powder is glutaraldehyde cross-linked gelatin, derived from type A gelatin extracted from pigskin.
Arthrone Co., Ltd. | China's First Domestic Innovation—Artica® Zirconia Ceramic Femoral Head
January 8, 2025Arthrone Co., Ltd. (hereinafter referred to as Arthrone) announced that its developed zirconia ceramic femoral head product obtained certification from the National Medical Products Administration (NMPA) on January 8, 2025, with the registration certificate number GuoXieZhuZhun 20243132300.
This marks that Arthrone's innovative achievements in the field of high-end medical ceramic materials have officially gained recognition in the Chinese market, filling the gap in the domestic production of high-performance ceramic femoral heads and surpassing international competitors in multiple performance indicators.
This product is a component of a hip joint prosthesis, made from zirconia ceramic material. It is designed to work in conjunction with other components from the same series by the same manufacturer and is suitable for hip joint replacement. The use of high and low-temperature cyclic sintering technology reduces the high-temperature sintering point, providing the driving force for grain boundary diffusion while avoiding performance issues caused by excessively high temperatures. Compared with metal femoral heads, zirconia ceramic femoral heads exhibit chemical inertness that effectively prevents the release of metal ions, reducing the occurrence of prosthesis loosening, while also offering better biocompatibility.
Hangzhou Weida Biomaterials Technology Co., Ltd. | China's First Cotton-like Absorbable Artificial Bone
On May 1, 2024, the first cotton-like absorbable composite artificial bone in China, developed by Hangzhou Weida Biomaterials Technology Co., Ltd., was approved for marketing.(Registration Certificate No.: National Medical Device Registration Certificate 20243131040)
It is reported that the product has the following features:
1. Material Innovation:This product is composed of medical-grade organic polymers and calcium phosphate salts, forming a white, flexible, cotton-like fibrous mass, which is an innovation in material science.
2. Malleability:Compared with traditional powdered, granular, and block artificial bones, cotton-like artificial bones have better malleability, can be arbitrarily shaped during surgery, are convenient for filling, and improve surgical efficiency.
3.Mechanical Strength:The mechanical strength of the molded cotton-like artificial bone is significantly improved, reaching the level of human cortical bone, which ensures the stability of bone defect repair.
4. High Porosity:This product maintains nearly 80% porosity even after being filled and compacted, with interconnected pores resembling the structure of human trabecular bone. It provides excellent osteoconductivity and facilitates the ingrowth of bone cells.
5. Biodegradability:Cotton-like artificial bone can be 100% degraded and absorbed in the body within 6-12 months, achieving complete repair of bone defects without leaving any foreign objects in the body. The degradation rate matches the regeneration speed of the body's own bone tissue.
Kangxi Biomedical (Shenzhen) Co., Ltd. |The First Cartilage Regeneration Product in China to Obtain NMPA Class III Registration Certificate
April 2023COLTRIX® CartiRegen Collagen Cartilage Repair Scaffold ProductApproved for marketing in China, it is the first domestically developed cartilage regeneration product to receive a Class III NMPA registration certificate.It is also the first cartilage regeneration product to enter the "National Innovative Medical Device" channel.The core technology of this product is at an internationally leading level, filling the technical gap in this field in China and overcoming the worldwide challenge of cartilage's difficulty in regenerating after injury.
"Collagen Cartilage Repair Scaffold" product, used in conjunction with microfracture surgery, is suitable for cartilage defect repair with an area of 2-8 cm², classified as Outerbridge Grade III/IV (ICRS Grade III-IVa). A single minimally invasive arthroscopic surgery can repair the damaged articular cartilage, generating hyaline-like cartilage that closely resembles native cartilage.
During use, the collagen cartilage repair scaffold is implanted into the damaged area through arthroscopic surgery, providing a space for the adhesion, proliferation, and migration of autologous bone marrow mesenchymal stem cells (BMSCs). After the collagen cartilage repair scaffold is implanted, chondrocytes differentiate from BMSCs and migrate and proliferate from the surrounding healthy cartilage tissue. Chondrocytes continuously synthesize and secrete type II collagen, forming new cartilage tissue, thereby repairing the defective cartilage. In this process, the collagen scaffold gradually degrades, and the degradation products can be absorbed by chondrocytes as nutrients or excreted from the body through metabolism.
CCME Wisdom丨2025 Orthopedic & Dental Implant Conference
2025 Orthopedics & Dental Implant Conference —— The conference will focus on the entire industry chain of orthopedic and dental implants, covering all aspects from academia/research to product innovation and production/processing, providing a one-stop comprehensive platform to jointly promote the sustainable development and innovation of the orthopedic implant industry. The on-site exhibition area features over 150 booths, and companies in the orthopedic implant industry chain are welcome to showcase their latest products; contact Mr. Wu at 136 1282 0654.
Online Free Registration Channel